Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals

Journal of Experimental Medicine

Volumn 181, Issue 6, 1995, Pages 2029-2036

  Katsikis, Peter D ^a   Wunderlich, Eric S ^a   Smith, Craig A ^b   Herzenberg, Leonore A ^a   Herzenberg, Leonard A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; NERVE GROWTH FACTOR RECEPTOR; T LYMPHOCYTE ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; GENE ACTIVATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MEMORY CELL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, CD95; ANTIGENS, SURFACE; APOPTOSIS; CELLS, CULTURED; COMPARATIVE STUDY; FLOW CYTOMETRY; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMAN; LYMPHOCYTE ACTIVATION; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0029048581     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.181.6.2029     Document Type: Article

References (44)

1. Meyaard, L., S.A. Otto, R.R. Jonker, M.J. Mijnster, R.P. Keet, and F. Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science (Wash. DC). 257: 217-219.
2. Oyaizu, N., TW. McCloskey, M. Coronesi, N. Chirmule, V.S. Kalyanaraman, and S. Pahwa. 1993. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human im munodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood. 82: 3392-3400.
3. Groux, H., G. Torpier, D. Monte, Y. Mouton, A. Capron, and J.C. Ameisen. 1992. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp Med. 175: 331-340.
4. Fauci, A.S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science (Wash. DC). 262: 1011-1018.
5. Smith, C.A., T. Farrah, and R.G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76: 959-962.
6. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66: 233-243.
7. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75: 1169-1178.
8. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169: 1747-1756.
9. Trauth, B.C., C. Klas, A.M. Peters, S. Matzku, P. Moller, W. Falk, K.M. Debatin, and P.H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (Wash. DC). 245: 301-305.
10. Alderson, M.R., R.J. Armitage, E. Maraskovsky, TW. Tough, E. Roux, K. Schooley, F. Ramsdell, and D.H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp Med. 178: 2231-2235.
11. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (Wish. DC). 265: 528-530.
12. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (Lond.). 370: 650-652.
13. Dive, C., C.D. Gregory, D.J. Phipps, D.L. Evans, A.E. Milner, and A.H. Wyllie. 1992. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta. 1133: 275-285.
14. Moore, W.A., and R.A. Kautz. 1986. Data analysis in flow cytometry. In Handbook of Experimental Immunology. D.M. Weir, L.A. Herzenberg, C. Blackwell, and L.A. Herzenberg, editors. Blackwell Scientific Publications, Oxford. 30.1-30.
15. Mower, D.A., D.W. Peckham, V.A. Illera, J.K. Fishbaugh, L.L. Stunz, and R.F. Ashman. 1994. Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J. Immunol. 152: 4832-4842.
16. Nicoletti, I., G. Migliorati, M.C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139: 271-279.
17. Wognum, A.W., G. Krystal, C.J. Eaves, A.C. Eaves, and P.M. Lansdorp. 1992. Increased erythropoietin-receptor expression on CD34-positive bone marrow cells from patients with chronic myeloid leukemia. Blood. 79: 642-649.
18. Tartaglia, L.A., R.F. Weber, I.S. Figari, C. Reynolds, M. Palladino, Jr., and D.V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA. 88: 9292-9296.
19. Smith, C.A., H.J. Gruss, T. Davis, D. Anderson, T. Farrah, E. Baker, G.R. Sutherland, C.I. Brannan, N.G. Copeland, N.A. Jenkins, et al. 1993. CD30 antigen, a marker for Hodgkin’s lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell. 73: 1349-1360.
20. Alderson, M.R., C.A. Smith, T.W. Tough, T. Davis-Smith, R.J. Armitage, B. Falk, E. Roux, E. Baker, G.R. Sutherland, W.S. Din, et al. 1994. Molecular and biological characterization of human 4-IBB and its ligand. Eur. J. Immunol. 24: 2219-2227.
21. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149: 3753-3758.
22. Schnittman, S.M., H.C. Lane, J. Greenhouse, J.S. Justement, M. Baseler, and A.S. Fauci. 1990. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. USA. 87: 6058-6062.
23. van Noesel, C.J.M., R.A. Gruters, F.G. Terpstra, P.T.A. Schellekens, R.A.W. van Lier, and F. Miedema. 1990. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J. Clin. Invest. 86: 293-299.
24. Meyaard, L., S.A. Otto, I.P.M. Keet, M.T.L. Roos, and F. Miedema. 1994. Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease. J. Clin. Invest. 93: 982-988.
25. Tedder, T.F., T. Matsuyama, D. Rothstein, S.F. Schlossman, and C. Morimoto. 1990. Human antigen-specific memory T cells exress the homing receptor (LAM-1) necessary for lymphocyte recirculation. Eur. J. Immunol. 20: 1351-1355.
26. Tsuji, T., R. Nibu, K. Iwai, H. Kanegane, A. Yachie, H. Seki, T. Miyawaki, and N. Taniguchi. 1994. Efficient induction of immunoglobulin production in neonatal naive B cells by memory CD4+ T cell subset expressing homing receptor Lselectin. J. Immunol. 152: 4417-4424.
27. Hanabuchi, S., M. Koyanagi, A. Kawasaki, N. Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kobayashi, S. Yonehara, H. Yagita, and K. Okumura. 1994. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA. 91: 4930-4934.
28. Clerici, M., F.T. Hakim, D.J. Venzon, S. Blatt, C.W. Hendrix, T.A. Wynn, and G.M. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91: 759-765.
29. Ramsdell, F., M.S. Seaman, R.E. Miller, K.S. Picha, M.K. Kennedy, and D.H. Lynch. 1994. Differential ability of T(h)l and T(h)2 T cells to express fas ligand and to undergo activation-induced cell death. Int. Immunol. 6: 1545-1553.
30. Uehara, T., T. Miyawaki, K. Ohta, Y. Tamaru, T. Yokoi, S. Nakamura, and N. Taniguchi. 1992. Apoptotic cell death of primed CD45RO + T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood. 80: 452-458.
31. Muro-Cacho, C.A., G. Pantaleo, and A.S. Fauci. Analysis of apoptosis in lymph nodes of HIV-infected individuals. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. In press.
32. Bonyhadi, M.L., L. Rabin, S. Salimi, D.A. Brown, J. Kosek, J.M. McCune, and H. Kaneshima. 1993. HIV induces thymus depletion in vivo. Nature (Land.). 363: 728-732.
33. Watanabe-Fukunaga, R., C.I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N.A. Jenkins, and S. Nagata. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148: 1274-1279.
34. Springer, G.G. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1: 365-371.
35. Kobayashi, N., Y. Hamamoto, N. Yamamoto, A. Ishii, M. Yonehara, and S. Yonehara. 1990. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc. Natl. Acad. Sci. USA. 87: 9620-9624.
36. Schnittman, S.M., M.C. Psallidopoulos, H.C. Lane, L. Thompson, M. Baseler, F. Massari, C.H. Fox, N.P. Salzman, and A.S. Fauci. 1989. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4 (published erratum appears in Science, Vol. 245, Aug. 18,1993, preceding p. 694. Science (Wash. DC). 245: 305-308.
37. Schnittman, S.M., J.J. Greenhouse, M.C. Psallidopoulos, M. Baseler, N.P. Salzman, A.S. Fauci, and H.C. Lane. 1990. Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann. Intern. Med. 113: 438-443.
38. Wang, Z.Q., A. Dudhane, T. Orlikowsky, K. Clarke, X. Li, Z. Darzynkiewicz, and M.K. Hoffmann. 1994. CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur. J. Immunol. 24: 1549-1552.
39. Banda, N.K., J. Bernier, D.K. Kurahara, R. Kurrle, N. Haigwood, R.P. Sekaly, and T.H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gpl20 primes T cells for activation-induced apoptosis. J. Exp. Med. 176: 1099-1106.
40. Wang, Z.Q., T. Orlikowsky, A. Dudhane, R. Mittler, M. Blum, E. Lacy, G. Riethmuller, and M.K. Hoffmann. 1994. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gpl20 and gpl20-specific antibodies from AIDS patients. Eur. J. Immunol. 24: 1533-1557.
41. Estaquier, J., T. Idziorek, F. Debels, F. Barresinoussi, B. Hurtrel, A.M. Aubertin, A. Venet, M. Mehtali, E. Muchmore, P. Michel, et al. 1994. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl. Acad. Sci. USA. 91: 9431-9435.
42. Callebaut, C., B. Krust, E. Jacotot, and A.G. Hovanessian. 1993. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. Science (Wash. DC). 262: 2045-2050.
43. Gutheil, W.G., M. Subramanyam, G.R. Flentke, D.G. Sanford, E. Munoz, B.T. Huber, and W.W. Bachovchin. 1994. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat’s immunosuppressive activity. Proc Natl. Acad. Sci. USA. 91: 6594-6598.
44. Lu, Y.Y., Y. Koga, K. Tanaka, M. Sasaki, G. Kimura, and K. Nomoto. 1994. Apoptosis induced in CD4+ cells expressing gpl60 of human immunodeficiency virus type 1. J. Virol. 68: 390-399.